Data from First-in-Human Trial targeting CISH a Novel Immune Checkpoint, in Patients with Metastatic Colorectal Cancer Presented at 2025 American Association for Cancer Research (AACR) Annual Meeting Read Press Release Contact A clinical-stage company focused on a next-generation small molecule checkpoint inhibitor CISH IMMUNE CHECKPOINT TARGET THE NEXT GENERATION OF CANCER PLATFORM TECHNOLOGY CISH: a … Continue reading Home Page